Marlies Bode

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Role of the Anaphylatoxin Receptor C5aR2 in Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage.

Role of the Anaphylatoxin Receptor C5aR2 in Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage.

Journal: American journal of hypertension

Published: February 28, 2024

Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage.

Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: November 01, 2023

Ibrutinib-associated focal segmental glomerulosclerosis and the impact of podocin mutations in chronic lymphocytic leukemia.

Ibrutinib-associated focal segmental glomerulosclerosis and the impact of podocin mutations in chronic lymphocytic leukemia.

Journal: Kidney international

Published: March 29, 2023

Complement component C3 as a new target to lower albuminuria in hypertensive kidney disease.

Complement component C3 as a new target to lower albuminuria in hypertensive kidney disease.

Journal: British journal of pharmacology

Published: October 05, 2022

Finerenone Reduces Renal RORγt γδ T Cells and Protects against Cardiorenal Damage.

Finerenone Reduces Renal RORγt γδ T Cells and Protects against Cardiorenal Damage.

Journal: American journal of nephrology

Published: February 04, 2022

The role of the mineralocorticoid receptor in immune cells in cardiovascular disease.

The role of the mineralocorticoid receptor in immune cells in cardiovascular disease.

Journal: British journal of pharmacology

Published: August 23, 2021

Immune mechanisms in arterial hypertension. Recent advances.

Immune mechanisms in arterial hypertension. Recent advances.

Journal: Cell and tissue research

Published: September 23, 2020

The role of complement in arterial hypertension and hypertensive end organ damage.

The role of complement in arterial hypertension and hypertensive end organ damage.

Journal: British journal of pharmacology

Published: April 09, 2020

B6.Rag1 Knockout Mice Generated at the Jackson Laboratory in 2009 Show a Robust Wild-Type Hypertensive Phenotype in Response to Ang II (Angiotensin II).

B6.Rag1 Knockout Mice Generated at the Jackson Laboratory in 2009 Show a Robust Wild-Type Hypertensive Phenotype in Response to Ang II (Angiotensin II).

Journal: Hypertension (Dallas, Tex. : 1979)

Published: February 21, 2020

Adaptive immunity and IL-17A are not involved in the progression of chronic kidney disease after 5/6 nephrectomy in mice.

Adaptive immunity and IL-17A are not involved in the progression of chronic kidney disease after 5/6 nephrectomy in mice.

Journal: British journal of pharmacology

Published: March 07, 2018

Salt, inflammation, IL-17 and hypertension.

Salt, inflammation, IL-17 and hypertension.

Journal: British journal of pharmacology

Published: March 06, 2018

A pathogenic role of complement in arterial hypertension and hypertensive end organ damage.

A pathogenic role of complement in arterial hypertension and hypertensive end organ damage.

Journal: American journal of physiology. Heart and circulatory physiology

Published: November 14, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026